Weaponizing the Microbiome Against Alzheimer’s Disease
Time: 8:00 am
- Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know?
- Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it
- Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progression